Smokescreen Genotyping Array & Software
Addiction & Smoking Genetics Research
Key Facts
About BioRealm
BioRealm operates as a specialized service provider and product developer in the genomics and data science space, serving academic, government, and industry clients. The company's core expertise lies in applying advanced statistical methods, including Bayesian analysis and machine learning, to complex genetic and multi-omics data across a wide range of therapeutic areas. Its most significant proprietary asset is the Smokescreen® Genotyping Array, developed with support from the National Institute on Drug Abuse (NIDA), which provides an end-to-end solution for addiction genetics research. With nearly two decades of collective team experience, BioRealm positions itself as a trusted partner for reproducible and transparent research, operating with HIPAA-compliant standards.
View full company profile